Guidance for Industry: Standards for Clinical Trials in Type 2 Diabetes in Canada

Health Canada is issuing this guidance for clinical trials in type 2 diabetes to provide clarification on the interpretation of the Canadian Diabetes Association Clinical Practice Guidelines (CDA-CPG)Footnote1 in relation to clinical trial applications under Part C, Division 5 of the Food and Drug Regulations.

Données et ressources

Info additionnelle

Champ Valeur
Source
Version
Producteur
Courriel de l'auteur
Mainteneur
Courriel du mainteneur
Data Level
Agreement Required
Purpose Constraints
Redistribution Allowed
AI Training Allowed
Data Steward
Title (French) Ligne directrice : Normes applicables aux essais cliniques sur le diabète de type 2 au Canada
Update Frequency as_needed
Geographic Scope []
Criticality Level []
Sensitivity Level unrestricted
Langue
Contact Person
Contact Email
Dictionnaire de données
Open Canada Date Published 2007-09-04 00:00:00
Open Canada Date Modified
Open Canada Subject ["health_and_safety"]
Open Canada Keywords {"fr": ["lignes directrices pour l'industrie", "normes", "essais cliniques sur le diabète de type 2", "lignes directrices de pratique clinique de l'Association canadienne du diabète", "CDA-CPG", "Règlement sur les aliments et drogues"], "en": ["guidance for industry", "standards", "clinical trials in type 2 diabetes", "Canadian Diabetes Association Clinical Practice Guidelines", "CDA-CPG", "Food and drug Regulations"]}
Open Canada Collection publication
Principal Organization
Reference Data
Official Source